Table 1 Clinical characteristics of 41 RA patients at follow-up visit (T6)
From: Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis
| Variables | Results |
|---|---|
| Demographic variables: | |
| Age, years | 53.3 (8.7) (28–68) |
| Gender, F/M | 34 (82.9)/ 7 (17) |
| Cardiovascular risk factors: | |
| Family history of CVD | 20 (48.8) |
| Current/Ex-smokers | 23 (56.1) |
| Hypertension | 17 (41.5) |
| Diabetes | 3 (7.3) |
| CKD3a (eGFR 45–59 ml/min/1.73 m2) | 2 (4.9) |
| AI abnormal | 11 (26.8) |
| BMI > 30 kg/m2 | 5 (12.2) |
| Physical inactivity | 23 (56.1) |
| RA related variables | |
| Disease duration, years | 19.2 (9.2) (8–45) |
| Erosions (X-ray of hands/feet) | 35 (85.4) |
| Extra-articular symptoms | 28 (68.3) |
| Positive RF-IgM | 33 (80.5) |
| Positive anti-CCP2 | 30 (73.2) |
| ESR, mm/h | 19.2 (16.0) (2–64) |
| CRP, mg/l | 14.35 (37.5) (0.1–228.5) |
| Average CRP (6 years), mg/l | 11.02 (9.9) (0.9–37.3) |
| Low RA activity (DAS28 ≤ 3.2) | 23 (56.1) |
| Current glucocorticoid use | 18 (43.9) |
| Current conventional synthetic DMARD | 39 (95.1) |
| Current biological DMARD | 32 (78.1) |